<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01528631</url>
  </required_header>
  <id_info>
    <org_study_id>1AP029010911</org_study_id>
    <nct_id>NCT01528631</nct_id>
  </id_info>
  <brief_title>The Effects of D-Fagomine on Glycaemic Response to Sucrose in Men</brief_title>
  <official_title>Randomized Controlled Double-blind Nutritional Intervention Trial to Evaluate the Effects of D-fagomine on Glycaemic Response to Sucrose in Men</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bioglane</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Rovira i Virgili</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Technological Centre of Nutrition and Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Research Council, Spain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bioglane</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the effect of D-fagomine on glycaemic response to
      sucrose in men.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine and compare glycaemic response to sucrose of D-Fagomine and control in the
      timeframe of 180 minutes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycaemic response to sucrose</measure>
    <time_frame>0-180 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insulin in venous plasma</measure>
    <time_frame>0-180 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Glycaemic Response</condition>
  <condition>Insulinemic Response</condition>
  <arm_group>
    <arm_group_label>Control Product</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>200 ml water with 50g of sucrose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Product 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>200 ml water with 50g of sucrose and supplemented with 30 mg of D-Fagomine</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>D-Fagomine</intervention_name>
    <description>30 mg (initial dose), with 50 grams of sucrose in 200 ml of water.</description>
    <arm_group_label>Product 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>D-Fagomine</intervention_name>
    <description>0 mg (control) blended with 50 grams of sucrose in 200 ml of water.</description>
    <arm_group_label>Control Product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Males between the ages of 20 and 70 willing and able to provide written informed
        consent.

        Exclusion Criteria:

          1. LDL cholesterol levels higher than 189 mg/dl

          2. Triglycerides higher than 350 mg/dl (the threshold level to determine c-LDL using the
             Friedewald formula)

          3. Physical examinations and routine biochemical analysis shall be conducted to rule out
             pathologies.

          4. Consumption of supplements or acetylsalicylic acid

          5. Chronic alcoholism

          6. Body mass index (BMI) greater than 30 kg/m2

          7. Previous antihypertensive treatment at the start of the trial that has not finished at
             least 2 months before beginning the study

          8. Diabetes mellitus (if the fasting blood glucose is higher than 126 mg/dl, the test
             should be repeated and confirmed)

          9. Kidney disease (serum creatine levels above 1,4 mg/dl for women and above 1,5 mg/dl
             for men)

         10. Acute infectious diseases, malignant tumors, severe liver failure, respiratory failure
             associated with chronic or endocrine diseases

         11. Other conditions such as special dietary needs

         12. To be participating or having participated in a clinical trial within the last 3
             months

         13. Inability to continue the study

         14. History of gastrointestinal disease which may alter the absorption of nutrients

         15. Depressive disorder or thoughts of self-injury
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rosa Solà, PhD MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Rovira i Virgili</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitari Sant Joan, Universitat Rovira i Virgili</name>
      <address>
        <city>Reus</city>
        <state>Tarragona</state>
        <zip>43204</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://www.bioglane.com</url>
    <description>BIOGLANE SLNE</description>
  </link>
  <link>
    <url>http://www.fagomine.com</url>
    <description>D-Fagomine</description>
  </link>
  <link>
    <url>http://www.ctns.cat</url>
    <description>CTNS - Technology Centre of Nutrition and Health</description>
  </link>
  <link>
    <url>http://www.urv.cat</url>
    <description>URV - Rovira i Virgili University</description>
  </link>
  <reference>
    <citation>Gómez L, Molinar-Toribio E, Calvo-Torras MÁ, Adelantado C, Juan ME, Planas JM, Cañas X, Lozano C, Pumarola S, Clapés P, Torres JL. D-Fagomine lowers postprandial blood glucose and modulates bacterial adhesion. Br J Nutr. 2012 Jun;107(12):1739-46. doi: 10.1017/S0007114511005009. Epub 2011 Oct 3.</citation>
    <PMID>22017795</PMID>
  </reference>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2012</study_first_submitted>
  <study_first_submitted_qc>February 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2012</study_first_posted>
  <last_update_submitted>July 24, 2012</last_update_submitted>
  <last_update_submitted_qc>July 24, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 25, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

